SONIM TECHNOLOGIES INC — Director's Dealing 2026

Feb 10, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DNA X, Inc. (SONM)
CIK: 0001178697
Period of Report: 2026-02-09

Reporting Person: MULICA MICHAEL C (Director, Acting CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-09	Common Stock	A	50000	$0.00	Acquired	54071	Direct

Footnotes

F1: Represents the grant of restricted stock units that vest in equal monthly installments over a one-year period following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F2: Consists of (i) 4,071 shares of common stock and (ii) 50,000 unvested restricted stock units.

F3: The number of securities reported herein reflects the effects of a 1-for-18 reverse stock split effected by the Issuer on October 27, 2025, which was exempt from reporting pursuant to Rule 16a-9.